Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,007 | 159,737 | 220,976 | 179,618 | 158,286 |
| Receivables | 1,859 | 419 | 419 | 1,195 | 1,560 |
| Other current assets | 34,620 | 17,163 | 15,439 | 30,770 | 37,540 |
| TOTAL | $161,486 | $177,319 | $236,834 | $211,583 | $197,386 |
| Non-Current Assets | |||||
| PPE Net | 10,772 | 10,675 | 9,904 | 10,296 | 10,504 |
| Intangibles | 3,563 | 3,563 | 3,563 | 3,563 | 3,563 |
| Other Non-Current Assets | 2,664 | 800 | 800 | 794 | 931 |
| TOTAL | $16,999 | $15,038 | $14,267 | $14,653 | $14,998 |
| Total Assets | $178,485 | $192,357 | $251,101 | $226,236 | $212,384 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,583 | 25,743 | 19,863 | 21,398 | 29,496 |
| Accrued Expenses | 28,022 | 24,875 | 19,184 | 19,279 | 24,133 |
| Other current liabilities | 6,879 | 6,391 | 7,979 | 2,610 | 2,768 |
| TOTAL | $56,376 | $58,386 | $108,284 | $92,920 | $106,018 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 892 | 1,377 | 61,258 | 49,633 | 49,621 |
| Other Non-Current Liabilities | 102,109 | 101,749 | 178,156 | 167,371 | 68,146 |
| TOTAL | $102,755 | $102,249 | $204,765 | $200,194 | $113,295 |
| Total Liabilities | $159,131 | $160,635 | $313,049 | $293,114 | $219,313 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,147 | 43,653 | 43,381 | 39,142 | 39,103 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -537,322 | -461,401 | -545,340 | -475,373 | -409,985 |
| Other shareholders' equity | -1,803 | -1,712 | -1,579 | -1,321 | -1,123 |
| TOTAL | $19,354 | $31,722 | $-61,948 | $-66,878 | $-6,929 |
| Total Liabilities And Equity | $178,485 | $192,357 | $251,101 | $226,236 | $212,384 |